POGO, December 9, 2020. FDA’s coronavirus vaccine panel did not include experts who raised concerns about Pfizer’s data at a previous meeting.
Read More »Tag: covid vaccine
Testimony of Dr. Diana Zuckerman of NCHR before the FDA Advisory Committee on Pfizer COVID Vaccine
December 10, 2020: We need longer-term data on the Pfizer COVID-19 vaccine to fully understand if benefits outweigh the risks for frail patients and all races/ethnicities, and for everyone else as well. It is essential that FDA ensure the continuation of the randomized controlled trial.
Read More »Public Comments Regarding ACIP Meeting on December 1, 2020
December 1, 2020: We are concerned about the lack of data on the vaccines in patients living in long-term care facilities, or any patients over 65 years of age.
Read More »Will Covid-19 vaccines save lives? Current trials aren’t designed to tell us
October 21, 2020, BMJ. Current Covid-19 vaccine trials don’t give the public enough information on whether the vaccine is safe or will work for everyone.
Read More »HEALTH CARE BRIEFING: FDA Vaccine Rules Challenged as Weak
Bloomberg Gov, October 23, 2020. Scientists and advocates challenge coronavirus vaccine testing standards at FDA advisory meeting.
Read More »